{
  "docId": "019f6b8f-1840-747c-b048-7afedf31e31d",
  "docSlug": "jarvis-ey-how-fit-is-your-capital-allocation-strategy",
  "documentTitle": "EY How fit is your capital allocation strategy",
  "authorId": "ey-how-fit-is-your-capital-allocation-strategy",
  "authorName": null,
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 10,
  "pageCount": 24,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 24,
  "notes": "The chart shows four lines: Top tier, Median, Activist targets, and Bottom tier from 2009 to 2014.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019f6b8f-1840-747c-b048-7afedf31e31d/10",
  "deckHref": "/decks/019f6b8f-1840-747c-b048-7afedf31e31d",
  "deckJsonHref": "/decks/019f6b8f-1840-747c-b048-7afedf31e31d.json",
  "deckAnchorHref": "/decks/019f6b8f-1840-747c-b048-7afedf31e31d#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.3,
        "y": 0.2
      },
      "kind": "callout",
      "text": "Companies with TSRs in this range in 2014 face elevated activism risk",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "481085eb-8887-4c65-93c3-5dfe779429b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Cumulative total shareholder return (TSR) from 2009 to 2014 for Top tier, Median, Activist targets, and Bottom tier companies.",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42a9aac8-0755-4f1b-8fdc-9d718cdbdc37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.25,
        "x": 0.7,
        "y": 0.3
      },
      "kind": "list",
      "text": "31 biopharma companies in data set, including four that were targets of activism in 2013 or 2014",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "296b75be-0cb9-4ff8-98ea-ffe926845655",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Source: EY and Capital IQ. Company financials were calculated through 31 December 2014. See ey.com/vitalsigns for full analysis.",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b82a2ce1-2580-44b2-b5fd-642f01bb3d6b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Total shareholder return as a performance measure: bottom tier at greater risk of activism",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cf4ef007-fb40-4e67-8738-633663807324",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "76f82a39-8f05-4ff8-82f4-f0fc09782ce7",
      "evidence": "chart/line: Cumulative total shareholder return (TSR) from 2009 to 2014",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "activist-defense",
      "slug": null,
      "matchId": "b238780c-0f68-4c8d-a7c1-5a602e4aa882",
      "evidence": "The slide explicitly links low TSR performance to the risk of shareholder activism.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 7,
      "beatId": "2ee61659-cd45-4e64-8c84-7f31031fa91a",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The document provides data and analysis to support its claims.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}